Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes (2024)
- Authors:
- USP affiliated authors: MACHADO NETO, JOÃO AGOSTINHO - ICB ; VICARI, HUGO PASSOS - ICB ; SILVA, JEAN CARLOS LIPRERI DA - ICB ; CARVALHO, MARIA FERNANDA LOPES - ICB ; LIMA, KELI CRISTINA DE - FM
- Unidades: ICB; FM
- DOI: 10.21037/tcr-24-1091
- Subjects: FARMACOLOGIA; LEUCEMIA MIELOIDE AGUDA; CITOESQUELETO; HEMATOPOESE; EXPRESSÃO GÊNICA; MONÓCITOS; MUTAÇÃO; MICRORNAS; GRANULÓCITOS; BIOINFORMÁTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Translational Cancer Research
- ISSN: 2219-6803
- Volume/Número/Paginação/Ano: v. 13, n. 11, p. 6105-6116, 2024
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
VICARI, Hugo Passos et al. Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes. Translational Cancer Research, v. 13, n. 11, p. 6105-6116, 2024Tradução . . Disponível em: https://dx.doi.org/10.21037/tcr-24-1091. Acesso em: 01 abr. 2026. -
APA
Vicari, H. P., Silva, J. C. L. da, Carvalho, M. F. L., Lima, K., & Machado Neto, J. A. (2024). Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes. Translational Cancer Research, 13( 11), 6105-6116. doi:10.21037/tcr-24-1091 -
NLM
Vicari HP, Silva JCL da, Carvalho MFL, Lima K, Machado Neto JA. Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes [Internet]. Translational Cancer Research. 2024 ; 13( 11): 6105-6116.[citado 2026 abr. 01 ] Available from: https://dx.doi.org/10.21037/tcr-24-1091 -
Vancouver
Vicari HP, Silva JCL da, Carvalho MFL, Lima K, Machado Neto JA. Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes [Internet]. Translational Cancer Research. 2024 ; 13( 11): 6105-6116.[citado 2026 abr. 01 ] Available from: https://dx.doi.org/10.21037/tcr-24-1091 - New molecular targets in acute leukemias: cytoskeletal regulatory proteins
- NSC305787, a pharmacological ezrin inhibitor, exhibits antineoplastic activity in pancreatic cancer cells
- Transcriptomics analysis identified ezrin as a potential druggable target in cervical and gastric cancer cells
- Comprehensive analysis of the HCK gene in myeloid neoplasms: insights into biological functions, prognosis, and response to antineoplastic agents
- Ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia
- Obatoclax reduces cell viability of acute myeloid leukemia cell lines independently of their sensitivity to venetoclax
- Cellular and molecular effects of Eribulin in preclinical models of hematologic neoplasms
- ARHGAP6 transcript levels are associated with molecular risk and impact survival outcomes in acute myeloid leukemia
- CDC7 (cell division cycle 7)
- Synthesis and evaluation of 2-substituted quinazolin-4(3H)-ones as potential antileukemic agents
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
